Sign In
Buy BCEL
$0.0900
+0 (+0%)
At Close: Sep 13, 2024
Atreca to Present at Upcoming Investor Conferences
04:30pm, Tuesday, 02'nd Aug 2022
SAN CARLOS, Calif., Aug. 02, 2022 (GLOBE NEWSWIRE) -- Atreca, Inc. (Atreca) (NASDAQ: BCEL), a clinical-stage biotechnology company focused on developing novel therapeutics generated through a unique d
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Cellino Biotech, Inc., an autonomous cell therapy technology platform company, today announced the expansion of its executive leadership team with the appointments o
Atreca to Present at Upcoming Investor Conferences
04:30pm, Thursday, 19'th May 2022
SAN CARLOS, Calif., May 19, 2022 (GLOBE NEWSWIRE) -- Atreca, Inc. (Atreca) (NASDAQ: BCEL), a clinical-stage biotechnology company focused on developing novel therapeutics generated through a unique di
Atreca: Biotech With Promise Based On First Candidate ATRC-101
01:14pm, Friday, 22'nd Apr 2022
Preliminary evidence shows that ATRC-101 helps those patients with higher target expression; 8 out of 12 patients (66%) who took ATCR-101 with H-score ≥ 50 responded. Phase 1b study was updated to
Atreca to Present at Upcoming Virtual Investor Conferences
08:05pm, Friday, 08'th Apr 2022 GlobeNewswire Inc.
SAN CARLOS, Calif., April 08, 2022 (GLOBE NEWSWIRE) -- Atreca, Inc. (Atreca) (NASDAQ: BCEL), a clinical-stage biotechnology company focused on developing novel therapeutics generated through a uniqu
Atreca to Present at Upcoming Virtual Investor Conferences
04:05pm, Friday, 08'th Apr 2022
SAN CARLOS, Calif., April 08, 2022 (GLOBE NEWSWIRE) -- Atreca, Inc. (Atreca) (NASDAQ: BCEL), a clinical-stage biotechnology company focused on developing novel therapeutics generated through a unique
HC Wainwright Sees 'Multiple Catalyst Opportunities' After Atreca Inks Licensing Pact With Zymeworks
01:26pm, Wednesday, 06'th Apr 2022 Benzinga
Atreca Inc (NASDAQ: BCEL) announced a licensing agreement with Zymeworks Inc (NYSE: ZYME) to utilize their ZymeLink technology to develop novel antibody-drug conjugates (ADCs).
The agreement incl
Atreca Announces Expansion of Preclinical Pipeline
08:01pm, Tuesday, 05'th Apr 2022 GlobeNewswire Inc.
Atreca Announces Licensing Agreement with Zymeworks
Atreca to Host Virtual R&D Day on Tuesday, April 5, 2022
12:00pm, Wednesday, 23'rd Mar 2022 GlobeNewswire Inc.
SAN CARLOS, Calif., March 23, 2022 (GLOBE NEWSWIRE) -- Atreca, Inc. (Atreca) (NASDAQ: BCEL), a clinical-stage biotechnology company focused on developing novel therapeutics generated through a uniqu
Atreca down 32% on more than 5x higher than normal volume
05:26pm, Monday, 07'th Mar 2022 Seeking Alpha
Atreca (BCEL) stock has fallen 32% today after the stock rose nearly 211% on March 4 following the release of quarterly earnings after the bell the day before.
Clover Health, Monte Rosa top healthcare gainers; Atreca, Biophytis lead losers'' pack
03:01pm, Monday, 07'th Mar 2022 Seeking Alpha
Clover Health Investments (CLOV) +18%. Monte Rosa Therapeutics (GLUE) +12%. Atreca (BCEL) -30%. Biophytis (BPTS) -14%.
Can Atreca, Inc. (BCEL) Climb 310% to Reach the Level Wall Street Analysts Expect?
03:00pm, Monday, 07'th Mar 2022 Zacks Investment Research
The consensus price target hints at a 310.2% upside potential for Atreca, Inc. (BCEL). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings est
Has Atreca, Inc. (BCEL) Outpaced Other Medical Stocks This Year?
02:40pm, Monday, 07'th Mar 2022 Zacks Investment Research
Here is how Atreca, Inc. (BCEL) and Indivior PLC (INVVY) have performed compared to their sector so far this year.
Has Atreca, Inc. (BCEL) Outpaced Other Medical Stocks This Year?
11:16am, Monday, 07'th Mar 2022
Here is how Atreca, Inc. (BCEL) and Indivior PLC (INVVY) have performed compared to their sector so far this year.
Best Penny Stocks to Watch This Week? 3 For Your Watch List
08:06pm, Sunday, 06'th Mar 2022 PennyStocks
Are these penny stocks on your watch list for this week?
The post Best Penny Stocks to Watch This Week? 3 For Your Watch List appeared first on Penny Stocks to Buy, Picks, News and Information | Penny
